Prokarium
London
About Prokarium
Prokarium is a biopharmaceutical company leading the oncology field of microbial immunotherapy The Company’s pipeline is designed to unlock a new generation of immuno-oncology therapeutics by re engineering evolution into a synthetic biology platform Prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrating immune driven, long lasting antitumor effects
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $78.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2023)
- Website: prokarium.com
Industries & Categories
Biotechnology, Genetics, Health Care, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/prokarium-93043 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.